3.05 USD
↗ 0.09 (3.04%)AT CLOSE (03:59 PM EST)
Protalix BioTherapeutics, Inc. Common Stock
PLXAMEX • USD
3.05
↘ 0.01 (0.16%)
POST MARKET (AS OF 08:15 PM EST)
Post Market
AS OF 08:15 PM EST
3.05
↘ 0.01 (0.16%)
Market: CLOSED
Protalix BioTherapeutics, Inc. Common Stock (PLX) is currently trading at $3.05. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (25.5%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest PLX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 13, 2026.
Open?$2.94
High?$3.05
Low?$2.85
Prev. Close?$2.96
Volume?1.6M
Avg. Volume?985.1K
VWAP?$2.95
Rel. Volume?1.61x
Bid / Ask
Bid?$2.81 × 100
Ask?$3.03 × 200
Spread?$0.22
Midpoint?$2.92
Valuation & Ratios
Market Cap?257.2M
Shares Out?84.3M
Float?75.0M
Float %?93.1%
P/E Ratio?12.51
P/B Ratio?3.19
EPS?$0.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Employees
226
Market Cap
257.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1996-01-02
Address
2 UNIVERSITY PLAZA
HACKENSACK, NJ 07601
Phone: 201-696-9345
HACKENSACK, NJ 07601
Phone: 201-696-9345
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?23
Short Sent.?42
Piotroski F-Score?4/9Mixed
Altman Z-Score?6.21Safe
Confidence?53%Low
Short InterestHigh
Short % of Float?4.64%Low
Short Interest?3.5M
Days to Cover?6.2
Free Float75.0M
Avg Daily Volume563.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.27Strong
Quick Ratio?2.14Strong
Cash Ratio?0.73Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score89/100
P/E?12.5CHEAP▾
Peers100
S&P89
P/B?3.19FAIR▾
Peers100
S&P53
P/S?3.04FAIR▾
Peers100
S&P50
P/FCF?17.1CHEAP▾
Peers100
S&P66
EV/EBITDA?8.8CHEAP▾
Peers100
S&P87
EV/Sales?2.78CHEAP▾
Peers100
S&P64
Returns & Efficiency
ROE?25.5%STRONG▾
Peers50
S&P75
ROA?17.4%STRONG▾
Peers50
S&P91
Cash Flow & Enterprise
FCF?$15.1M
Enterprise Value?$235.1M
Fundamentals ratios updated end of day